Park Medi World IPO: Price, Analysis, Allotment, And GMP

Park Medi World IPO - Company Analysis

Park Medi World IPO, a Mainboard IPO, is a bookbuilding issue of Rs. 920 Cr by Park Medi World Ltd., as of March 31, 2025 and is a chain of private hospitals mainly in North India, had 3,000 beds available.

Internal medicine, neurology, urology, gastrointestinal, general surgery, orthopaedics, and oncology are just a few of the more than thirty super specialty and specialty services that Park Hospital provides.

As of September 30, 2025, each hospital has 67 operating theaters (OTs), 870 intensive care unit (ICU) beds, and an oxygen-producing plant to assist critical care.

Park Medi World IPO Details

The Park Medi World Ltd IPO open date is from Dec 10 to Dec 12, with IPO allotment on Dec 15, refund initiation on Dec 16, 2025.

The Rs. 920 Cr mainline IPO comprises a 4.75 crore shares (Rs. 770 Cr) and offer for sale of 0.93 crore shares (Rs. 150 Cr).

The Park Medi World IPO listing date might be on Wednesday, 17 December 2025, and it will be listed at the BSE and NSE. The Park Medi World IPO price band is Rs. 154 to Rs. 162 for each Share. 

Events	Date
IPO Opening Date	December 10, 2025
IPO Closing Date	December 12, 2025
IPO Allotment Date	December 15, 2025 (Tentative)
Refund Initiation	December 16, 2025 (Tentative)
Tentative IPO Listing Date	December 17, 2025

 

Industry Outlook

If you want to apply for the IPO, click to open a Demat Account.

 

Company Financial 

(Amount in Cr)

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	2,133.70	1,912.10	1,592.82
Total Income	1,425.97	1,263.08	1,272.18
PAT	213.22	152.01	228.19
EBITDA	372.17	310.30	390.34
Net Worth	1,021.86	815.98	667.55
Reserves & Surplus	1,049.40	858.63	653.09
Total Borrowing	682.07	686.71	575.68

 

Cash Flows

The cash flows for various activities are shown below:

(Amount in Mn)

Net Cash Flow In Multiple Activities	FY25	FY24	FY23
Net Cash Flow Operating Activities	1,911.51	3,614.35	1,950.29
Net Cash Flow Investing Activities	(911.67)	(2,545.52)	(1,796.31)
Net Cash Flow Financing Activities	(736.06)	(1,303.02)	15.14

 

Revenue Bifurcation 

(Source RHP)

The Objective of The Issue

• Payback or prepayment, in whole or in part, of some outstanding loans that the company and some of its subsidiaries have taken out. ~ Rs. 380 Cr.

• Funding capital expenditures for our specific subsidiaries, Park Medicity (NCR) and Blue Heavens to build a new hospital and expand an existing one, respectively. ~ Rs. 60.50 Cr.

• Providing funding for the company and its specific subsidiaries, Blue Heavens and Ratangiri, to buy medical equipment. ~ Rs. 27.46 Cr.

Click to check the IPO application status.

Listed Peers of Park Medi World Ltd.

Company Name	Face Value (₹)	EPS (₹)	P/E (x)
Apollo Hospitals Enterprise Ltd.	5	100.56	73.43
Fortis Healthcare Ltd.	10	10.26	90.42
Narayana Hrudalaya Ltd.	10	38.90	50.10
Max Healthcare Institute Ltd.	10	11.07	101.54
Krishna Institute of Medical Sciences Ltd.	2	9.61	69.53
Global Health Ltd.	2	17.92	66.41
Jupiter Lifeline Hospitals Ltd.	10	29.47	48.59
Yatharth Hospital & Trauma Care Services Ltd	10	14.72	52.85

 

Valuation

KPI	Values
ROE	20.68%
ROCE	17.47%
Debt/Equity	0.61
RoNW	20.08%
PAT Margin	15.30%
EBITDA Margin	26.71%
Price to Book Value	6.09

 

 

Evaluation of P/E Ratio

The company's IPO price of Rs. 162 corresponds to a P/E multiple of 29.18x based on FY25 EPS of Rs. 5.55.

Explore the Orkla India IPO.

IPO's Strengths

• The biggest private hospital chain in Haryana and the second largest chain in North India.

• Providing inexpensive, high-quality healthcare with a wide range of specialties.

• Successful acquisition and integration of hospitals in the past.

• Excellent financial and operational results with a varied payor mix.

• A competent management team with experience in the sector, led by a doctor.

IPO Weaknesses

• If any of these contracts are canceled, not renewed, or lost in subsequent bids, it might have a major impact on revenue, operations, and business expansion.

• Dialysis operations are inherently risky from a clinical, operational, reputational, and legal standpoint. Any failure to maintain essential quality standards, such as patient care, personnel, and medical protocols, could lead to litigation, lawsuits, reputational damage and patient loss.

• Business disruptions can result from both internal issues and external events.  Significant financial losses and long-term reputational damage could come from such interruptions.

Park Medi World IPO GMP 

Park Medi World IPO GMP today is Rs. 0 as of 05 Dec 2025, while writing this information with a price band set at Rs. 162. This suggests that the estimated listing price of the IPO could be around Rs. 162, indicating a gain/loss of 0% per Share.

Park Medi World Limited IPO Summary

IPO Opening & Closing Date	Dec 10, 2025 to Dec 12, 2025
Face Value	Rs. 2 per Share
Issue Price	Rs. 154 to Rs. 162
Lot Size	92 Shares
Issue Size	5,67,90,123 Shares (Rs. 920 Cr)
Offer for Sale	92,59,259 Shares (Rs. 150 Cr)
Fresh Issue	4,75,30,864 Shares (Rs. 770 Cr)
Listing At	BSE, NSE
Issue Type	Book Built Issue IPO
Registrar	Kfin Technologies Ltd.

 

Park Medi World IPO Lot Size

The Park Medi World Ltd. IPO allows retail investors to invest in a minimum and maximum of 1 Lot (92 Shares) amounting to Rs. 14904 and 13 Lots (1196 Shares) amounting to Rs. 193752, respectively, while for S-HNI investors, the minimum Lot is 14 (1288 Shares) amounting to Rs. 208656.

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	13 Lots
SHNI (Minimum)	14 Lots
SHNI (Maximum)	67 Lots
BHNI (Minimum)	68 Lots

Park Medi World IPO Reservation

Institutional Share Portion	50%
Retail Investors' Share Portion	35%
Non-Institutional Shares Portion	15%

 

Park Medi World IPO Allotment Status

To check the Park Medi World IPO allotment status, visit the official Registrar’s website or the BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of Park Medi World  Ltd.

• Dr. Ajit Gupta

• Dr. Ankit Gupta. 

Pre-Issue Promoter Shareholding	95.55%
Post-Issue Promoter Shareholding	82.89%

 

Park Medi World IPO Lead Managers

• Nuvama Wealth Management Ltd. 

• CLSA India Pvt.Ltd. 

• Dam Capital Advisors Ltd. 

• Intensive Fiscal Services Pvt. Ltd. 

Dividend Policy

The company has not paid a dividend during the last three years during the past three financial years.

 

 

Conclusion

Park Medi World IPO offers investors exposure to a fast-growing Indian pharmaceutical company with solid financial performance, robust margins and a varied product range. However, as the offer is completely an OFS with no additional capital infusion, investors should weigh growth potential against value and sector concerns. 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.